Ericksen Research & Development

Clinton, Utah 84015

0 studies enrolling now · 12 studies all time

What they study most

ADHD, Acute Gouty Arthritis, Acute Otitis Externa, Adjunctive Treatment of Major Depressive Disorder, Attention Deficit Hyperactivity Disorder, Attention Deficit Hyperactivity Disorder (ADHD), Attention-Deficit/Hyperactivity Disorder, Attention-Deficit/Hyperactivity Disorder (ADHD), Autism, Sleep Disorders

Studies at this site

• Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) — Running, not enrolling
• Treatment of Impulsive Aggression (IA) in Adolescent With ADHD in Conjunction With Standard ADHD Treatment — Stopped early
• Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities — Completed
• Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 2) — Completed
• A Trial of CM-AT in Children With Autism With All Levels of FCT (The Blum Study) — Completed
• Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD — Completed
• Evaluation of SPN-812 (Viloxazine Extended-release Capsule) High Dose in Children With ADHD — Completed
• Evaluation of SPN-812 (Viloxazine Extended-release Capsule) High Dose in Adolescents With ADHD — Completed
• Comparative Efficacy and Safety of Ciprofloxacin 0.3% and Dexamethasone 0.1% in Acute Otitis Externa — Completed
• A Study to Evaluate Efficacy and Safety of Anakinra in the Treatment of Acute Gouty Arthritis — Completed
• Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder (CLARITY) — Completed
• A Trial of CM-AT in Children With Autism- Open Label Extension Study — Completed